These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33963858)

  • 1. Preparation of loratadine nanocrystal tablets to improve the solubility and dissolution for enhanced oral bioavailability.
    Li J; Zhou Y; Aisha M; Wu J; Wang H; Huang F; Sun M
    J Pharm Pharmacol; 2021 Jun; 73(7):937-946. PubMed ID: 33963858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple and low-energy method to prepare loratadine nanosuspensions for oral bioavailability improvement: preparation, characterization, and in vivo evaluation.
    Yang D; Li R; Zhang F; Qin L; Peng F; Jiang S; He H; Lu X; Zhang P
    Drug Deliv Transl Res; 2020 Feb; 10(1):192-201. PubMed ID: 31482518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
    Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
    Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation.
    Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanosized-Loratadine Embedded Orodispersible Films for Enhanced Bioavailability: Scalable Preparations and Characterizations.
    Van Nguyen K; Nguyen HT; Nghiem LHT; Van Can M; Tran TH
    AAPS PharmSciTech; 2022 Feb; 23(3):78. PubMed ID: 35194702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Characterization of Venetoclax Nanocrystals for Oral Bioavailability Enhancement.
    Kala SG; Chinni S
    AAPS PharmSciTech; 2021 Mar; 22(3):92. PubMed ID: 33683477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
    Sun W; Ni R; Zhang X; Li LC; Mao S
    Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Abiraterone Acetate Nanocrystal Tablets to Enhance Oral Bioavailability: Formulation Optimization, Characterization, In Vitro Dissolution and Pharmacokinetic Evaluation.
    Liu Y; Li Y; Xu P; Shen Y; Tang B; Wang Q
    Pharmaceutics; 2022 May; 14(6):. PubMed ID: 35745707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an oral rutin nanocrystal formulation.
    Mauludin R; Müller RH; Keck CM
    Int J Pharm; 2009 Mar; 370(1-2):202-9. PubMed ID: 19114097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiallergic Treatment of Bariatric Patients: Potentially Hampered Solubility/Dissolution and Bioavailability of Loratadine, but Not Desloratadine, Post-Bariatric Surgery.
    Porat D; Dukhno O; Vainer E; Cvijić S; Dahan A
    Mol Pharm; 2022 Aug; 19(8):2922-2936. PubMed ID: 35759355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Surfactant-free Lipid-based Formulation for Improving Oral Bioavailability of Loratadine Using Colloidal Silicon Dioxide as Emulsifier and Solid Carrier.
    Huang R; Tan Y; Shen L; Wang T; Quan D
    Curr Pharm Biotechnol; 2018; 19(3):217-223. PubMed ID: 29745326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers.
    Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S
    Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Evaluation of Novel Solid Self-Nanodispersion Delivery System for Andrographolide.
    Xu J; Ma Y; Xie Y; Chen Y; Liu Y; Yue P; Yang M
    AAPS PharmSciTech; 2017 Jul; 18(5):1572-1584. PubMed ID: 27620195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coamorphous Loratadine-Citric Acid System with Enhanced Physical Stability and Bioavailability.
    Wang J; Chang R; Zhao Y; Zhang J; Zhang T; Fu Q; Chang C; Zeng A
    AAPS PharmSciTech; 2017 Oct; 18(7):2541-2550. PubMed ID: 28224393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.
    Miao X; Sun C; Jiang T; Zheng L; Wang T; Wang S
    J Pharm Pharm Sci; 2011; 14(2):196-214. PubMed ID: 21733409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering of solidified glyburide nanocrystals for tablet formulation via loading of carriers: downstream processing, characterization, and bioavailability.
    Ali HSM; Hanafy AF; Alqurshi A
    Int J Nanomedicine; 2019; 14():1893-1906. PubMed ID: 30936692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation.
    Alshweiat A; Katona G; Csóka I; Ambrus R
    Eur J Pharm Sci; 2018 Sep; 122():94-104. PubMed ID: 29908301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent.
    Tran TH; Poudel BK; Marasini N; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Feb; 443(1-2):50-7. PubMed ID: 23318367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
    Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
    Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.